{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:40:49Z","timestamp":1793148049726,"version":"4.5.0"},"reference-count":46,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by multiple hormonal and metabolic abnormalities, including insulin resistance, hyperandrogenism, and disturbances in lipid and carbohydrate metabolism. The objective of this study is to assess the quality of life of women diagnosed with polycystic ovary syndrome (PCOS) and to identify any factors within the study group that may impact the scores related to quality of life. Materials and Methods: This research was carried out among women diagnosed with PCOS. An original questionnaire, developed through an online Google Forms survey, was utilized as the research instrument and distributed through social networks and support groups to women facing PCOS. This study encompassed a participant pool of 200 women with PCOS, aged 24 years or older. For the analytical component, Pearson\u2019s \u03c72 test was employed\u2014a nonparametric test designed to assess the relationship between two variables measured on a qualitative scale. The chosen level of statistical significance was set at p &lt; 0.05. Results: The analysis revealed that the quality of life of the women under study was not linked to the duration of the disease or comorbidities. However, a significant association was observed with the inconvenience caused by PCOS symptoms. Women experiencing very bothersome symptoms of PCOS reported a lower quality of life compared to those with symptoms rated as not very bothersome. Despite the majority of women with PCOS rating their quality of life as good or very good, they often find the associated symptoms of PCOS bothersome. Women reporting lower quality of life tend to acknowledge the impact of PCOS on their lives, experience a sense of lack of control over the disease, struggle with depression, and do not accept their physical appearance. Conclusions: Hence, the support from specialists like endocrinologists, gynecologists, and nutritionists becomes crucial for many women dealing with PCOS. Adopting a healthy lifestyle, incorporating a balanced diet, and engaging in regular physical activity can assist in managing the troublesome symptoms of PCOS, thereby enhancing overall quality of life. In instances of emotional difficulties, seeking psychological support is equally important, and the significance of support and acceptance from loved ones should not be overlooked.<\/jats:p>","DOI":"10.3390\/medicina60020294","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T03:53:46Z","timestamp":1707450826000},"page":"294","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Quality of Life of Women with Polycystic Ovary Syndrome"],"prefix":"10.3390","volume":"60","author":[{"given":"Natalia","family":"Ligocka","sequence":"first","affiliation":[{"name":"Department of Maternal and Child Health, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-8353","authenticated-orcid":false,"given":"Karolina","family":"Chmaj-Wierzchowska","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-7060","authenticated-orcid":false,"given":"Katarzyna","family":"Wszo\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Wilczak","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-8250","authenticated-orcid":false,"given":"Katarzyna","family":"Tomczyk","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.17219\/acem\/59380","article-title":"The pathogenesis and treatment of polycystic ovary syndrome: What\u2019s new?","volume":"26","author":"Bednarska","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.52336\/acm.2022.023","article-title":"Skin lesions in polycystic ovary syndrome","volume":"11","author":"Maj","year":"2022","journal-title":"Aesth Cosmetol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.18544\/PEDM-23.04.0094","article-title":"Metabolic disorders in polycystic ovary syndrome","volume":"23","author":"Wikiera","year":"2017","journal-title":"Pediatr. Endocrino Diabetes Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2003.11.027","article-title":"Insulin resistance and metformin in polycystic ovary syndrome","volume":"115","author":"Yogev","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_5","first-page":"133","article-title":"Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease","volume":"57","author":"Martikainen","year":"1998","journal-title":"Int. J. Circumpolar Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"Petraglia","year":"2003","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2008.04.009","article-title":"Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights","volume":"119","author":"Westerveld","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Singh, S., Pal, N., Shubham, S., Sarma, D.K., Verma, V., Marotta, F., and Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041454"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gleicher, N., Darmon, S., Patrizio, P., and Barad, D.H. (2022). Reconsidering the Polycystic Ovary Syndrome (PCOS). Biomedicines, 10.","DOI":"10.3390\/biomedicines10071505"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of Polycystic Ovary Syndrome. Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature","volume":"9193","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Christ, J.P., and Cedars, M.I. (2023). Current Guidelines for Diagnosing PCOS. Diagnostics, 13.","DOI":"10.3390\/diagnostics13061113"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS","volume":"101","author":"Dokras","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, Z., Groen, H., Cantineau, A.E.P., van Elten, T.M., Karsten, M.D.A., van Oers, A.M., Mol, B.W.J., Roseboom, T.J., and Hoek, A. (2021). Dietary Intake, Eating Behavior, Physical Activity, and Quality of Life in Infertile Women with PCOS and Obesity Compared with Non-PCOS Obese Controls. Nutrients, 13.","DOI":"10.3390\/nu13103526"},{"key":"ref_16","first-page":"17","article-title":"Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH","volume":"18","author":"Mohammad","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., and Ee, C. (2023). Lifestyle management in polycystic ovary syndrome\u2014Beyond diet and physical activity. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-022-01208-y"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shahid, R., Iahtisham-Ul-Haq Mahnoor Awan, K.A., Iqbal, M.J., Munir, H., and Saeed, I.J. (2022). Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). Food Biochem., 46.","DOI":"10.1111\/jfbc.14117"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00404-019-05202-z","article-title":"Quality of life among infertile PCOS patients","volume":"300","author":"Angin","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/IJWH.S165794","article-title":"Measures of health-related quality of life in PCOS women: A systematic review","volume":"10","author":"Moghadam","year":"2018","journal-title":"Int. J. Womens Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13048-023-01171-9","article-title":"Depression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects","volume":"16","author":"Mojahed","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_22","first-page":"46","article-title":"Bipolar disorder in women with polycystic ovarian syndrome (PCO)","volume":"52","author":"Ghajarzadeh","year":"2014","journal-title":"Acta Med. Iran."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological wellbeing in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Human. Reprod."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sidra, S., Tariq, M.H., Farrukh, M.J., and Mohsin, M. (2019). Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223329"},{"key":"ref_25","first-page":"61","article-title":"The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis","volume":"13","author":"Bazarganipour","year":"2015","journal-title":"Iran. J. Reprod. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Rzo\u0144ca, E., Bie\u0144, A., Wdowiak, A., Szyma\u0144ski, R., and Iwanowicz-Palus, G. (2018). Determinants of Quality of Life and Satisfaction with Life in Women with Polycystic Ovary Syndrome. Int. J. Environ. Res. Public. Health, 15.","DOI":"10.3390\/ijerph15020376"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.26444\/monz\/141154","article-title":"Lifestyle and psychosocial risks among women with polycystic ovary syndrome and insulin resistance","volume":"27","author":"Kolmaga","year":"2021","journal-title":"Med. Og. Nauk. Zdr."},{"key":"ref_28","first-page":"e28462","article-title":"Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review","volume":"14","author":"Shamim","year":"2022","journal-title":"Cureus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/IJWH.S145383","article-title":"Psychological burden among women with polycystic ovarian syndrome in Oman: A case-control study","volume":"9","author":"Sulaiman","year":"2017","journal-title":"Int. J. Womens Health"},{"key":"ref_30","first-page":"e13612","article-title":"The experience of women affected by polycystic ovary syndrome: A qualitative study from Iran","volume":"12","author":"Simbar","year":"2014","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.18544\/PEDM-24.01.0101","article-title":"Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty","volume":"24","author":"Grzyb","year":"2018","journal-title":"Pediatr. Endocrino Diabetes Metab."},{"key":"ref_32","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Siew","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e19644","DOI":"10.1097\/MD.0000000000019644","article-title":"The effect of exercise as an intervention for women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"99","author":"Ashe","year":"2020","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2006.11.073","article-title":"Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome","volume":"88","author":"Penna","year":"2007","journal-title":"Fertil. Steril."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.12775\/JEHS.2023.13.04.037","article-title":"Impact of various dietary interventions on the reduction of symptoms in polycystic ovary syndrome (PCOS)","volume":"13","author":"Kotusiewicz","year":"2023","journal-title":"J. Educ. Health Sport."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Greff, D., Juh\u00e1sz, A.E., V\u00e1ncsa, S., V\u00e1radi, A., Sipos, Z., Szinte, J., Park, S., Hegyi, P., Nyir\u00e1dy, P., and \u00c1cs, N. (2023). Inositol is an effective and safe treatment in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Reprod. Biol. Endocrinol., 21.","DOI":"10.1186\/s12958-023-01055-z"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"155223","DOI":"10.1016\/j.metabol.2022.155223","article-title":"Metformin: Is it a drug for all reasons and diseases?","volume":"133","author":"Triggle","year":"2022","journal-title":"Metabolism"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","article-title":"Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)","volume":"33","author":"Fruzzetti","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00228-023-03461-z","article-title":"Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized clinical trials","volume":"79","author":"Fontes","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e3217","DOI":"10.1210\/clinem\/dgac294","article-title":"Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome","volume":"107","author":"Hu","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: A \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil. Steril."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1210\/clinem\/dgab757","article-title":"Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization","volume":"107","author":"Zhu","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db20-0800","article-title":"Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke","volume":"70","author":"Zhu","year":"2021","journal-title":"Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1172750","DOI":"10.3389\/fendo.2023.1172750","article-title":"The relationship between polycystic ovary syndrome and coronary heart disease: A bibliometric analysis","volume":"14","author":"Liang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.fertnstert.2022.03.014","article-title":"Heart health in polycystic ovary syndrome: Time to act on the data","volume":"117","author":"Dokras","year":"2022","journal-title":"Fertil. Steril."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/2\/294\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:57:38Z","timestamp":1760104658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/2\/294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["medicina60020294"],"URL":"https:\/\/doi.org\/10.3390\/medicina60020294","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}